Evidence map›Paper›PMID 34195088›Full record

ArticleFrontiers in oncology2021

Implemented Interventions at the Naef K. Basile Cancer Institute to Protect Patients and Medical Personnel From COVID Infections: Effectiveness and Patient Satisfaction.

Jean El Cheikh, Samantha El Warrak, Nohra Ghaoui, Farouk Al Chami, Maya Shahbaz, Sarah Chehayeb, Nagi Saghir, Ali Bazarbachi, Ali Taher

Abstract read
In one paragraph

Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jean El CheikhBone Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Samantha El WarrakCancer Research Institute, Department of Internal medicine, Hematology/Oncology Division, American University of Beirut Medical Center, Beirut, Lebanon.
Nohra GhaouiCancer Research Institute, Department of Internal medicine, Hematology/Oncology Division, American University of Beirut Medical Center, Beirut, Lebanon.
Farouk Al ChamiCancer Research Institute, Department of Internal medicine, Hematology/Oncology Division, American University of Beirut Medical Center, Beirut, Lebanon.
Maya ShahbazFaculty of Sciences, Lebanese University, Beirut, Lebanon.
Sarah ChehayebDepartment of Nursing, Naef. K. Basile Cancer Institute, American University of Beirut Medical Center, Beirut, Lebanon.
Nagi SaghirDivision of Hematology/Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Ali BazarbachiBone Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Ali TaherDivision of Hematology/Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Coronavirus Disease 2019 (COVID-19) was declared a pandemic by WHO in March 2020. The first case of COVID-19 was identified in Lebanon on the 21

methodsOncology patients are amongst the immunosuppressed population, who are at greatest risk of contracting COVID-19 and consequently suffering its complications. In this manuscript, we evaluated the precautionary measures implemented at the NKBCI of AUBMC from March 1

resultsOur results involved 387 responses of oncology patients who visited the NKBCI during the period of March 1

conclusionNKBCI was competent in following the WHO guidelines in protecting the oncology patient population. Feedback collected from the surveys will be taken into account by the committee of the NKBCI to develop new safety measures that can better control viral spread while providing patient-centered medical care.

Indexed as

AUBMCCOVID-19interventionsNKBCIoncologysatisfaction

Identifiers

PMID34195088
PMCPMC8237752

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.